StonvexLoading…
StonvexStonvexStonvexCore line items from CHRW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.01B | $16.23B | $12.32B | $8.18B |
Operating Income | $175.69M | $794.96M | $613.61M | $392.77M |
Net Income | $147.23M | $587.08M | $450.76M | $152.47M |
EPS (Diluted) | $1.22 | $4.83 | $3.71 | $2.37 |
Total Assets | $5.24B | $5.06B | $5.23B | $5.32B |
Total Liabilities | $3.53B | $3.21B | $3.37B | $3.54B |
Cash & Equivalents | $159.66M | $160.87M | $136.84M | $155.99M |
Free Cash Flow OCF − CapEx | $65.96M | $894.89M | $592.49M | $323.02M |
Shares Outstanding | 118.16M | 118.43M | 118.42M | 118.32M |